Physiological and Oxidative Stress Basis of Lead Acetate-Induced Hepatic Dysfunction and the Protective Efficacy of Curcumin in Male Wistar Rats: An Integrated Biochemical, Morphometric, and Immunohistochemical Study
Keywords:
Lead acetate, curcumin, hepatotoxicity, oxidative stress, apoptosis, caspase-3, histopathology, fibrosisAbstract
Objective: Lead (Pb) is one of the most widespread environmental and occupational toxins in the world with liver being a major target organ for the various toxicological insults of lead. Lead acetate (PbAc) can cause a series of oxidative, inflammatory and apoptotic damages to the hepatic tissue and these mechanisms include the overproduction of reactive oxygen species (ROS), the dysfunction of the mitochondria and the depletion of antioxidant enzymes. The aim of the present study was to investigate the extensive alterations in hepatic tissue induced by sub-chronic exposure to PbAc, by using a combination of histological, histochemical, and immunohistochemical approaches, and to test the hepatoprotection of curcumin by integrated morphometric, biochemical and oxidative stress analysis.
Materials and methods: Thirty-two adult male Wistar rats were randomly divided into 4 groups (8 rats/each); Control, Curcumin (200 mg/kg/day), PbAc (20 mg/kg/day) and PbAc+Curcumin, which were fed by oral gavage for 60 days. The biochemical endpoints measured were serum liver function tests (ALT, AST, ALP, GGT, total bilirubin, albumin), blood lead level (atomic absorption spectrophotometry), hepatic oxidative stress markers (MDA, SOD, CAT, GPx, GSH), hepatic histopathology (H&E, Masson's trichrome, PAS), and immunohistochemistry (caspase-3, Ki-67). Quantitative morphometric analysis was performed with Image-Pro Plus software.
Results: PbAc-treated rats demonstrated significant hepatocellular degeneration, periportal fibrosis, marked elevation of serum liver enzymes (ALT: 87.6 ± 9.3 U/L; AST: 112.4 ± 11.7 U/L; p<0.001), profound oxidative stress (MDA: 6.47 ± 0.74 nmol/mg; SOD: 18.7 ± 2.9 U/mg; p<0.001), and elevated caspase-3 immunoreactivity (28.63 ± 3.74%). Curcumin co-administration significantly attenuated all these parameters (p<0.001), restoring hepatocellular architecture, normalizing antioxidant enzyme activities, and reducing apoptotic indices by 68.9%.
Conclusions: Biochemical, histomorphometric, and immunohistochemical evidence indicate that curcumin confers comprehensive hepatoprotection, mediated by its antioxidant, anti-apoptotic, anti-inflammatory, and anti-fibrotic activities, against PbAc-induced hepatotoxicity. The results offer solid scientific rationale for the therapeutic potential of curcumin in lead-induced liver disease.